<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34556492</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001049</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2021-001049</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The COVID-19 pandemic has led to over 100 million cases worldwide. The UK has had over 4 million cases, 400 000 hospital admissions and 100 000 deaths. Many patients with COVID-19 suffer long-term symptoms, predominantly breathlessness and fatigue whether hospitalised or not. Early data suggest potentially severe long-term consequence of COVID-19 is development of long COVID-19-related interstitial lung disease (LC-ILD).</AbstractText><AbstractText Label="METHODS AND ANALYSIS">The UK Interstitial Lung Disease Consortium (UKILD) will undertake longitudinal observational studies of patients with suspected ILD following COVID-19. The primary objective is to determine ILD prevalence at 12 months following infection and whether clinically severe infection correlates with severity of ILD. Secondary objectives will determine the clinical, genetic, epigenetic and biochemical factors that determine the trajectory of recovery or progression of ILD. Data will be obtained through linkage to the Post-Hospitalisation COVID platform study and community studies. Additional substudies will conduct deep phenotyping. The Xenon MRI investigation of Alveolar dysfunction Substudy will conduct longitudinal xenon alveolar gas transfer and proton perfusion MRI. The POST COVID-19 interstitial lung DiseasE substudy will conduct clinically indicated bronchoalveolar lavage with matched whole blood sampling. Assessments include exploratory single cell RNA and lung microbiomics analysis, gene expression and epigenetic assessment.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">All contributing studies have been granted appropriate ethical approvals. Results from this study will be disseminated through peer-reviewed journals.</AbstractText><AbstractText Label="CONCLUSION">This study will ensure the extent and consequences of LC-ILD are established and enable strategies to mitigate progression of LC-ILD.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Jim M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porter</LastName><ForeName>Joanna C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molyneaux</LastName><ForeName>Philip L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interstitial Lung Disease, Royal Brompton and Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interstitial Lung Disease, Royal Brompton and Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Iain</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-1340-2688</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Richard James</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aul</LastName><ForeName>Raminder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, St George's Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baillie</LastName><ForeName>John Kenneth</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0001-5258-793X</Identifier><AffiliationInfo><Affiliation>Roslin Institute, University of Edinburgh, Midlothian, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barratt</LastName><ForeName>Shaney L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Bristol Interstitial Lung Diseases Service, North Bristol NHS Trust, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beirne</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Academic Department of Respiratory Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaikley</LastName><ForeName>John F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooke</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhuri</LastName><ForeName>Nazia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3325-6996</Identifier><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Department, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collier</LastName><ForeName>Guilhem</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denneny</LastName><ForeName>Emma K</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0002-7695-325X</Identifier><AffiliationInfo><Affiliation>Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Docherty</LastName><ForeName>Annemarie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8250-6464</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibbons</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleeson</LastName><ForeName>Fergus V</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Department of Oncology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gooptu</LastName><ForeName>Bibek</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanley</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wythenshaw Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heightman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hillman</LastName><ForeName>Toby E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Simon R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0002-9837-2763</Identifier><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Mark G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Southampton NIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Fasihul</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0796-5724</Identifier><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawson</LastName><ForeName>Rod</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academic Department of Respiratory Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Puja</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life &amp; Medical Sciences, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Jane A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plat&#xe9;</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9957-0681</Identifier><AffiliationInfo><Affiliation>Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Respiratory, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poinasamy</LastName><ForeName>Krisnah</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Head of Research and Innovation Advocacy, Asthma UK, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quint</LastName><ForeName>Jennifer K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera-Ortega</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory Department, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Child Health, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>A John</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Djf</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interstitial Lung Disease, Royal Brompton and Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spears</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Perth Royal Infirmary, NHS Tayside, Perth, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spencer</LastName><ForeName>LIsa G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanel</LastName><ForeName>Stefan C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-9718-2952</Identifier><AffiliationInfo><Affiliation>Respiratory Department, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Diabetes, Endocrinology &amp; Gastroenterology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thickett</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Birmingham Acute Care Research Group, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acute and Respiratory Medicine, University Hospitals Birmingham Foundation Trust, Birmingham, uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>A A Roger</ForeName><Initials>AAR</Initials><AffiliationInfo><Affiliation>Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Simon Lf</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weatherley</LastName><ForeName>Nicholas D</ForeName><Initials>ND</Initials><Identifier Source="ORCID">0000-0001-5589-2219</Identifier><AffiliationInfo><Affiliation>Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weeks</LastName><ForeName>Mark Everard</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wootton</LastName><ForeName>Dan G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Infection Veterinary and Ecological Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brightling</LastName><ForeName>Chris E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-5803-5121</Identifier><AffiliationInfo><Affiliation>Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chambers</LastName><ForeName>Rachel C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0003-1370-9417</Identifier><AffiliationInfo><Affiliation>Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ling-Pei</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine Oncology, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Medical Imaging and Computing, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piper Hanley</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Diabetes, Endocrinology &amp; Gastroenterology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wain</LastName><ForeName>Louise V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>R Gisli</ForeName><Initials>RG</Initials><Identifier Source="ORCID">0000-0002-7929-2119</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK gisli.jenkins@imperial.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interstitial Lung Disease, Royal Brompton and Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/M008894/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/W006111/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1000861</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SP/14/6/31350</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20022</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S019669/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FS/18/13/33281</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T032529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19025</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="Y">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bronchoscopy</Keyword><Keyword MajorTopicYN="N">interstitial fibrosis</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34556492</ArticleId><ArticleId IdType="pmc">PMC8461362</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2021-001049</ArticleId><ArticleId IdType="pii">8/1/e001049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, et al. . Persistent post-COVID-19 interstitial lung disease. an observational study of corticosteroid treatment. Ann Am Thorac Soc 2021;18:799&#x2013;806. 10.1513/AnnalsATS.202008-1002OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, et al. . Physical, cognitive and mental health impacts of COVID-19 following hospitalisation: a multi-centre prospective cohort study. medRxiv 2021. 10.1101/2021.03.22.21254057</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254057</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Barratt SL, Condliffe R, et al. . Respiratory follow-up of patients with COVID-19 pneumonia. Thorax 2020;75:1009&#x2013;16. 10.1136/thoraxjnl-2020-215314</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020;8:807&#x2013;15. 10.1016/S2213-2600(20)30225-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30225-3</ArticleId><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Laura Fabbri SM, Khan F, Chi W. Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: a systematic review and meta-analysis. medRxiv 2021. 10.1101/2021.03.15.21253593</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.15.21253593</ArticleId><ArticleId IdType="pubmed">35338102</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Majumdar S, Singh R, et al. . Role of corticosteroid in the management of COVID-19: a systemic review and a clinician's perspective. Diabetes Metab Syndr 2020;14:971&#x2013;8. 10.1016/j.dsx.2020.06.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.054</ArticleId><ArticleId IdType="pmc">PMC7320713</ArticleId><ArticleId IdType="pubmed">32610262</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendeiro AF, Ravichandran H, Bram Y, et al. . The spatial landscape of lung pathology during COVID-19 progression. Nature 2021;593:564&#x2013;9. 10.1038/s41586-021-03475-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03475-6</ArticleId><ArticleId IdType="pmc">PMC8204801</ArticleId><ArticleId IdType="pubmed">33780969</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Wang Y. The clinical characteristics and risk factors of severe COVID-19. Gerontology 2021;67:255&#x2013;66. 10.1159/000513400</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513400</ArticleId><ArticleId IdType="pmc">PMC7900480</ArticleId><ArticleId IdType="pubmed">33406518</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ 2020;368:m1198. 10.1136/bmj.m1198</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1198</ArticleId><ArticleId IdType="pubmed">32217618</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Wong AW, Hague CJ, et al. . A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax 2021;76:402&#x2013;4. 10.1136/thoraxjnl-2020-216308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier GJ, Ho-Fung Chan JB, Hughes PJC. Imaging lung structure and function in acute COVID-19 patients with 129Xe and 1H MRI, 2021. ISMRM &amp; SMRT annual Meeting and Exhibition. Available: https://www.ismrm.org/21/program-files/D-133.htm</Citation></Reference><Reference><Citation>Chan H-F, Stewart NJ, Norquay G, et al. . 3D diffusion-weighted 129 Xe MRI for whole lung morphometry. Magn Reson Med 2018;79:2986&#x2013;95. 10.1002/mrm.26960</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.26960</ArticleId><ArticleId IdType="pmc">PMC5888195</ArticleId><ArticleId IdType="pubmed">29034509</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan H-F, Weatherley ND, Johns CS, et al. . Airway microstructure in idiopathic pulmonary fibrosis: assessment at hyperpolarized 3He diffusion-weighted MRI. Radiology 2019;291:223&#x2013;9. 10.1148/radiol.2019181714</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2019181714</ArticleId><ArticleId IdType="pubmed">30777806</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders LC, Eaden JA, Bianchi SM, et al. . Free breathing lung T1 mapping using image registration in patients with idiopathic pulmonary fibrosis. Magn Reson Med 2020;84:3088&#x2013;102. 10.1002/mrm.28342</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28342</ArticleId><ArticleId IdType="pubmed">32557890</ArticleId></ArticleIdList></Reference><Reference><Citation>Weatherley ND, Eaden JA, Hughes PJC, et al. . Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI. Thorax 2021;76:144&#x2013;51. 10.1136/thoraxjnl-2019-214375</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2019-214375</ArticleId><ArticleId IdType="pmc">PMC7815896</ArticleId><ArticleId IdType="pubmed">33273022</ArticleId></ArticleIdList></Reference><Reference><Citation>Weatherley ND, Stewart NJ, Chan H-F, et al. . Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF. Thorax 2019;74:500&#x2013;2. 10.1136/thoraxjnl-2018-211851</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2018-211851</ArticleId><ArticleId IdType="pmc">PMC6475110</ArticleId><ArticleId IdType="pubmed">30389827</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurance J. Home testing for coronavirus to track levels of infection in the community, 2020. Available: https://www.imperial.ac.uk/news/197217/home-testing-coronavirus-track-levels-infection/</Citation></Reference><Reference><Citation>Jacob J, Bartholmai BJ, Rajagopalan S, et al. . Predicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis. Am J Respir Crit Care Med 2018;198:767&#x2013;76. 10.1164/rccm.201711-2174OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201711-2174OC</ArticleId><ArticleId IdType="pmc">PMC6222463</ArticleId><ArticleId IdType="pubmed">29684284</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowling R. New national study into the long-term health impacts of COVID-19 launched. [on-line], 2020. Available: https://www.phosp.org/study-news/phosp-covid-launching-press-release/ [Accessed 05 Jun 2020].</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansell DM, Bankier AA, MacMahon H, et al. . Fleischner society: glossary of terms for thoracic imaging. Radiology 2008;246:697&#x2013;722. 10.1148/radiol.2462070712</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2462070712</ArticleId><ArticleId IdType="pubmed">18195376</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin GD, Ryerson CJ, Haramati LB, et al. . The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the fleischner Society. Chest 2020;158:106&#x2013;16. 10.1016/j.chest.2020.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7138384</ArticleId><ArticleId IdType="pubmed">32275978</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakubowski M, Turek-Jakubowska A, Szahidewicz-Krupska E, et al. . Profiling the endothelial function using both peripheral artery tonometry (EndoPAT) and laser doppler flowmetry (LD) - complementary studies or waste of time? Microvasc Res 2020;130:104008. 10.1016/j.mvr.2020.104008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2020.104008</ArticleId><ArticleId IdType="pubmed">32330479</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Spruit MA, Theunis J, et al. . Peripheral endothelial function is positively associated with maximal aerobic capacity in patients with chronic obstructive pulmonary disease. Respir Med 2018;142:41&#x2013;7. 10.1016/j.rmed.2018.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2018.07.013</ArticleId><ArticleId IdType="pubmed">30170800</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob J, Alexander D, Baillie JK, et al. . Using imaging to combat a pandemic: rationale for developing the UK national COVID-19 chest imaging database. Eur Respir J 2020;56. 10.1183/13993003.01809-2020. [Epub ahead of print: 13 08 2020].</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01809-2020</ArticleId><ArticleId IdType="pmc">PMC7331656</ArticleId><ArticleId IdType="pubmed">32616598</ArticleId></ArticleIdList></Reference><Reference><Citation>NHSX . National COVID-19 chest image database (NCCID), 2020. Available: https://nhsx.github.io/covid-chest-imaging-database/</Citation></Reference><Reference><Citation>Horowitz JE, et al. . Common genetic variants identify targets for COVID-19 and individuals at high risk of severe disease. medRxiv 2021. 10.1101/2020.12.14.20248176</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.14.20248176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaser A. Genetic risk of severe Covid-19. N Engl J Med 2020;383:1590&#x2013;1. 10.1056/NEJMe2025501</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2025501</ArticleId><ArticleId IdType="pmc">PMC7583681</ArticleId><ArticleId IdType="pubmed">33053291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauerbrei W, Perperoglou A, Schmid M, et al. . State of the art in selection of variables and functional forms in multivariable analysis&#x2014;outstanding issues. Diagn Progn Res 2020;4:3. 10.1186/s41512-020-00074-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41512-020-00074-3</ArticleId><ArticleId IdType="pmc">PMC7114804</ArticleId><ArticleId IdType="pubmed">32266321</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux PL, Cox MJ, Willis-Owen SAG, et al. . The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2014;190:906&#x2013;13. 10.1164/rccm.201403-0541OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201403-0541OC</ArticleId><ArticleId IdType="pmc">PMC4299577</ArticleId><ArticleId IdType="pubmed">25184687</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux PL, Willis-Owen SAG, Cox MJ, et al. . Host&#x2013;microbial interactions in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2017;195:1640&#x2013;50. 10.1164/rccm.201607-1408OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201607-1408OC</ArticleId><ArticleId IdType="pmc">PMC5476909</ArticleId><ArticleId IdType="pubmed">28085486</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, et al. . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475&#x2013;81. 10.1016/S2213-2600(20)30079-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux PL, Smith JJ, Saunders P, et al. . Bal is safe and well tolerated in individuals with idiopathic pulmonary fibrosis: an analysis of the profile study. Am J Respir Crit Care Med 2021;203:136&#x2013;9. 10.1164/rccm.202004-1138LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1138LE</ArticleId><ArticleId IdType="pmc">PMC7781115</ArticleId><ArticleId IdType="pubmed">32857629</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>